Ingenuity Systems entered into a three-year, $6 million Cooperative Research and Development Agreement with the FDA for the use of biomarkers to monitor drugs.
Jena, Germany 2/27/08—Laboratory automation supplier CyBio AG announced that it has appointed Dr. Holger Wolf as CEO effective March 1. Mr. Wolf was most recently vice president of Sales, Central Europe, for the Danish medical products firm Coloplast. He joins the company’s executive committee, whose other member is Sonja Strauss.
Metrohm introduced the 815 Robotic Titration Soliprep, 815 Robotic Filtration Soliprep and the 815 Robotic Flexible Soliprep for sample preparation of solid samples. Mettler-Toledo released Titration Excellence 2.0 software, the Rondo 30 sample changer and the DS800-TowPhase sensor for potentiometric surfactant titrations. Mettler-Toledo introduced the IPac and EQ-Pac lab qualification services. Sartorius AG introduced the […]
Holliston, MA 2/6/08—Harvard Bioscience announced that it has adopted a shareholders rights plan designed to protect the company in the case of a hostile takeover bid. Each stock holder will recive one preferred stock purchase right per share, which will become exercisable in the event of one person’s purchase of, or tender offer for, 20% […]
Under a comarketing alliance, CambridgeSoft will market Off-Label.com’s content via its Database Gateway. Phase Forward established a subsidiary within the facilities of its Indian partner, Virtusa, in Hyderabad, India, in November 2007. The Swiss Institute of Bioinformatics, the University of Geneva’s Proteome Informatics Group and Microsoft Research launched a two-year collaborative project to use MS […]
Triple quadrupole gas chromatography mass spectrometry (GC/MS) is a relatively small segment of the GC/MS market that has flown under the radar for several years, but now may become a more significant MS market segment. New entrants and recent instrument introductions indicate that there is a significant need for MS/MS capabilities in quadrupole-based GC/MS systems […]
Japanese R&D funding increased last year, but at a modest level, according to the latest data from the Japanese government. According to recent figures, the country’s total R&D spending rose in fiscal 2006 (April 2006–March 2007), continuing an upward trend, led by spending by private companies. In addition, government R&D funding is set to increase […]
Luminex launched the FlexmiR Select miRNA Select assay for the creation of customized RNA panels. Genetix released CloneMedia-HEK and CloneMedia-CHOK1. Millipore announced the “Stem Cell Tested” Initiative to ensure that many of its filter products are validated for use on stem cells, starting with the Stericup with Express PLUS membrane. Millipore launched its Tyrosine Kinases […]
Abeome granted Millipore an exclusive worldwide license to market and distribute the Human Embryonic Stem Cell Antigen-1 antibody for research use. In December 2007, EMD Chemicals’ Novagen brand licensed Luminex’s xMAP Technology platform in order to develop immunoassays for it. Rules-Based Medicine granted EMD Chemicals exclusive distribution rights to its quantitative protein multiplex assays, and […]
Paoli, PA 2/26/08—AMETEK has acquired Motion Control Group (MCG), a manufacturer of motors and motion control solutions for a range of markets, including the medical and life sciences markets. MCG generates annual sales of approximately $26 million. “MCG greatly enhances our capability in providing precision motion technology solutions,” stated AMETEK Chairman and CEO Frank S. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
